Comparative study of the effects of two antiglaucomatous drugs on the corneal thickness in rabbits with corneal autografts;Estudio comparativo de los efectos de dos drogas antiglaucomatosas sobre el espesor corneal en conejos con autoinjerto de córnea

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 83, Issue 4, 2008, Pages 257-261

  Chiaradia, Pablo A ^b,d   Casiraghi, J F ^b   Fischbarg, J ^a,c   Lavena, P I ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c NONE   (United States)

^d NONE   (Argentina)

Author keywords

Corneal thickness; Dorzolamide 2 ; Latanoprost 0.005 ; Pachymetry

Indexed keywords

ANTIHYPERTENSIVE AGENT; DORZOLAMIDE; LATANOPROST; PROSTAGLANDIN F; SULFONAMIDE; THIOPHENE DERIVATIVE;

ANIMAL; ARTICLE; COMPARATIVE STUDY; CORNEA; CORNEA TRANSPLANTATION; DRUG EFFECT; PATHOLOGY; RABBIT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CORNEA; CORNEAL TRANSPLANTATION; PROSTAGLANDINS F, SYNTHETIC; RABBITS; SULFONAMIDES; THIOPHENES;

EID: 42949171383     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Domingo Gordo B, Urcelay Segura JL, Conejero Arroyo J, Balado Vázquez P, Rodríguez Ausín P. Descompensación corneal en pacientes con compromiso endotelial tratados con dorzolamida tópica. Arch Soc Esp Oftalmol 2002; 77: 139-144.
2. Egan CA, Hodge DO, McLaren W, Bourne WM. Effect of dorzolamide on corneal endothelial function in normal human eyes. Invest Ophthalmol Vis Sci 1998; 39: 23-29.
3. Kaminski S, Hommer A, Koyuncu D, Biowski R, Barisani T, Baumgartner I. Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility. Acta Ophthalmol Scand 1998; 76: 78-79.
4. Lass JH, Khosrof SA, Laurence JK, Horwitz B, Ghosh K, Adamsons I. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol and betaxolol. Dorzolamide Corneal Effects Study Group. Arch Ophthalmol 1998; 116: 1003-1010.
5. Giasson CJ, Tram Nguyen TQ, Boisjoly HM, Lesk M, Amyot M, Charest M. Dorzolamide and corneal recovery from edema in patients with glaucoma or ocular hypertension. Am J Ophthalmol 2000; 129: 144-150.
6. Borderie V, Touzeau O, Bourcier T, Allouch C, Zito E, Laroche L. Outcome of graft central thickness after penetrating keratoplasty. Ophthalmology 2005; 112: 626-633.
7. Konowal A, Morrison JC, Brown VL, Cooke DL, Maguire J, Verdier DV, et al. Irreversible corneal descompensation in patients treated with topical dorzolamide. Am J Ophthalmol 1999; 127: 403-406.
8. Akiyama R, Kuang K, Koniarek JP, Chiaradia P, Roberts CW, Fischbarg J. Solutions containing miotic agents: effects on corneal transendothelial electrical potential difference. Graefe's Arch Clin Exp Ophthalmol 1997; 235: 379-383.
9. Kaufman H, Varnell E, Toshida H, Kanai A, Thompson H, Bazan. Effects of topical Unoprostone and Latanoprost on acute an recurrent herpetic keratitis in the rabbit. N Am J Ophthalmol 2001; 131: 643-646.